Neogenomics Inc
Change company Symbol lookup
Select an option...
NEO Neogenomics Inc
PACD Pacific Drilling SA
AUHEF Anhui Expressway Co Ltd
BAC Bank of America Corp
CMSQF Computershare Ltd
UNH UnitedHealth Group Inc
RYAAY Ryanair Holdings PLC
FNGO MicroSectors? FANG+? Index 2X Leveraged ETN
VIVC Vivic Corp
LAD Lithia Motors Inc
Go

Health Care : Life Sciences Tools & Services | Small Cap Growth
Company profile

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso Viejo, Fresno, Irvine, and West Sacramento, California; Houston, Texas and Nashville, and Tennessee. It offers testing services, which include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Immunohistochemistry (IHC), Molecular testing and Pathology consultation. Its Pharma Services and Clinical Trials group provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. It helps its customers develop a biomarker hypothesis by recommending an optimal platform for molecular screening and backing its discovery tools with the informatics to capture meaningful data.

Closing Price
$39.23
Day's Change
-2.12 (-5.13%)
Bid
--
Ask
--
B/A Size
--
Day's High
41.17
Day's Low
38.79
Volume
(Below Average)
Volume:
589,081

10-day average volume:
680,923
589,081

Display:

Providers:

UpdateCancel
6 providers
October 27, 2020
NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter

____________________ (1) Clinical tests exclude requisitions, tests, revenue and costs for Pharma Services and COVID-19 PCR tests. (2) The Company has provided adjusted financial information that has not been prepared in accordance with GAAP...(Accesswire)

October 13, 2020
NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China

NeoGenomics continues to build its world-class pharma clinical research capabilities to include servicing Greater China-based clinical trials FORT MYERS, FL / ACCESSWIRE / October 13, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of...(Accesswire)

October 01, 2020
NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020

FT. MYERS, FL / ACCESSWIRE / October 1, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its third quarter 2020 financial results on Tuesday, October 27...(Accesswire)

September 14, 2020
NeoGenomics To Virtually Participate In Fireside Chat At The 18th Annual Morgan Stanley Global Healthcare Conference

FT MYERS, FL / ACCESSWIRE / September 10, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, today announced that Doug VanOort, Chairman and Chief Executive Officer, Kathryn McKenzie, Chief...(Accesswire)

September 10, 2020
NeoGenomics To Virtually Participate In Fireside Chat At The 18th Annual Morgan Stanley Global Healthcare Conference

FT MYERS, FL / ACCESSWIRE / September 10, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, today announced that Doug VanOort, Chairman and Chief Executive Officer, Kathryn McKenzie, Chief...(Accesswire)

September 04, 2020
Diagnostic Methods Benefit from Rapidly Advancing Technologies

The diagnostics industry is a large and varied market, with new and innovative technology constantly being introduced. There are also various types of diagnostic methods including In Vitro Diagnostics (IVD), Point of Care (POC), Molecular...(PR Newswire)

August 31, 2020
(LD Micro) 360 Companies Set to Present this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.(Accesswire)

August 05, 2020
LD Micro - Announces Preliminary List of Presenters for the LD 500

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.(Accesswire)

August 03, 2020
Innovative Technological Advancements Improve Early Cancer Diagnoses

Cancer biomarkers have gained significant importance in the drug-development process in recent years. In particular, microarray technologies provide analysis of tens of thousands of molecules for a variety of assays, including drug binding...(PR Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.